Kirsi Pietiläinen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes (NCT04854083) | Kirsi Pietiläinen | 2022-02-17 |
Track Kirsi Pietiläinen automatically
Every clearance here is in the API, with alerts when new ones post.